Cargando…

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the most frequent kidney solid tumor, the clear cell RCC (ccRCC) being the major histological subtype. The probability of recurrence and the clinical behavior of ccRCC will greatly depend on the different clinical and histopathological features, already incorporated to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carril-Ajuria, Lucía, Santos, María, Roldán-Romero, Juan María, Rodriguez-Antona, Cristina, de Velasco, Guillermo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016957/ https://www.ncbi.nlm.nih.gov/pubmed/31861590 http://dx.doi.org/10.3390/cancers12010016

Ejemplares similares

Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Aili, Abudureyimujiang, et al.
Publicado: (2021)

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
por: Chen, Jiayi, et al.
Publicado: (2021)

PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma
por: Chowdhury, Basudev, et al.
Publicado: (2016)

Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma
por: Murakami, A, et al.
Publicado: (2017)

Immune Checkpoint Inhibitor Combination Therapy versus Sunitinib as First-Line Treatment for Favorable-IMDC-Risk Advanced Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials
por: Manneh, Ray, et al.
Publicado: (2022)

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2017)

Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway
por: Gad, Sophie, et al.
Publicado: (2021)

PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma
por: Saiga, Kazuho, et al.
Publicado: (2022)

Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis
por: Demirel, Emin, et al.
Publicado: (2023)

An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
por: Wang, Yuanyuan, et al.
Publicado: (2016)

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma()
por: Bihr, Svenja, et al.
Publicado: (2019)

Comments on “Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis”
por: Pontes-Silva, André, et al.
Publicado: (2023)

PBRM1 deficiency oncogenic addiction is associated with activated AKT–mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells
por: Tang, Yu, et al.
Publicado: (2022)

A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial
por: de Velasco, Guillermo, et al.
Publicado: (2020)

Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial
por: de Velasco, Guillermo, et al.
Publicado: (2022)

Erratum to: An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
por: Wang, Yuanyuan, et al.
Publicado: (2016)

PBRM1 Regulates Stress Response in Epithelial Cells
por: Porter, Elizabeth G., et al.
Publicado: (2019)

Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.
por: Carretero-González, Alberto, et al.
Publicado: (2021)

Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma
por: Gatto, Francesco, et al.
Publicado: (2016)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2022)

Prognostic value of immune-related genes in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2’-Deoxycytidine
por: Gu, Di, et al.
Publicado: (2022)

Role of the Pbrm1 subunit and the PBAF complex in Schwann cell development
por: Polanetzki, Vanessa, et al.
Publicado: (2022)

Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2018)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Prognostic value of peripheral blood T lymphocyte subsets in clear cell renal cell carcinoma
por: Zhou, Yihong, et al.
Publicado: (2021)

Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma
por: Li, Mingrui, et al.
Publicado: (2022)

Analyzing and validating the prognostic value and immune microenvironment of clear cell renal cell carcinoma
por: Ke, Jingwei, et al.
Publicado: (2022)

The expression and prognostic value of RNA binding proteins in clear cell renal cell carcinoma
por: Li, Can-Xuan, et al.
Publicado: (2020)

Comprehensive exploration of the expression and prognostic value of AQPs in clear cell renal cell carcinoma
por: Wang, Huanrui, et al.
Publicado: (2022)

Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma
por: Li, Rong, et al.
Publicado: (2023)

Prognostic and Predictive Values of Subcellular Localisation of RET in Renal Clear-Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2016)

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis
por: Espana-Agusti, Judit, et al.
Publicado: (2017)

Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2021)

PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway
por: Wang, HongKai, et al.
Publicado: (2017)

Pbrm1 intrinsically controls the development and effector differentiation of iNKT cells
por: Wang, Xin, et al.
Publicado: (2022)

Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2017)

Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma
por: Luo, Ting, et al.
Publicado: (2018)

Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma
por: Fan, Bo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8p7216f0mcitrfn23msmklj4js